1-1 of 1
Mark A. Reid
Close
Sort by
Journal Articles

Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia

Clinical Trials & Observations
Kerry A. Rogers, Ying Huang, Amy S. Ruppert, Farrukh T. Awan, Nyla A. Heerema, Corinne Hoffman, Gerard Lozanski, Kami J. Maddocks, Mollie E. Moran, Mark A. Reid, Margaret Lucas, Jennifer A. Woyach, W. Thomas Whitlow, Jeffrey A. Jones, John C. Byrd
Journal: Blood
Blood (2018) 132 (15): 1568–1572.
https://doi.org/10.1182/blood-2018-05-853564
Published: 2018
Includes: Supplemental data